Open Source Innovation in the Context of Pharma and Biotech

 


Open Source Innovation in the context of pharma and biotech is an issue based deliverable that gives an overview of this space and analyses the key drivers and barriers of this area. It gives an overview of the key problems faced by the pharmaceutical industry today, past, present and future strategies to tackle these problems, new strategies to improve R&D productivity, advantages of open source innovation, obstacles of this concept, possible solutions to overcome these hurdles, and the future of open source innovation. It also discusses the case studies of some of the major open source innovation initiatives from around the world.

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

Table of Contents

Open Source Innovation in the Context of Pharma and Biotech, Issue Based Deliverable on Open Source Innovation in the Context of Pharma and BiotechAnalysis of Open Source Innovation in the Context of Pharma and BiotechOverview of Open Source Innovation in the Context of Pharma and Biotech




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.